Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021)
Dentsply Sirona (XRAY) reported Current Deferred Revenue of $68.0 million for Q4 2021, up 28.3% on a YoY basis from $53.0 million in Q4 2020, and up 28.3% quarter-over-quarter from $53.0 million in Q4 2020.
Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021) Analysis & Trends
Dentsply Sirona has reported Current Deferred Revenue for 4 years, with the latest figure at $68.0 million in Q4 2021.
- For the quarter ending Q4 2021, Current Deferred Revenue rose 28.3% year-over-year to $68.0 million; the trailing twelve-month figure through Dec 2021 stood at $68.0 million (up 28.3% YoY), and the FY2021 full-year result was $68.0 million, up 28.3% from the prior year.
- Current Deferred Revenue for Q4 2021 stood at $68.0 million, up from $53.0 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $68.0 million in Q4 2021, with the low at $53.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Dentsply Sirona | 2.09 Bn | 1.90 Bn | 427.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | 53.00 Mn |
| Dec 31, 2010 | 5.66 Mn |
| Dec 31, 2009 | 3.39 Mn |